Action A007570 ILYANG PHARMACEUTICAL CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Ilyang Pharmaceutical Co.,Ltd

Actions

A007570

KR7007570005

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 10/05/2024 		Varia. 5j. Varia. 1 janv.
13 940 KRW +0,22% Graphique intraday de Ilyang Pharmaceutical Co.,Ltd +1,09% -10,93%
2023 Ilyang Pharmaceutical Co.,Ltd publie ses résultats pour le premier trimestre clos le 31 mars 2023 CI
2023 Ilyang Pharmaceutical Co. Ltd (KOSE:A007570) annonce un rachat d'actions pour une valeur de 2.000 millions KRW. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.
Ilyang Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on March 10, 2022, has expired with 118,321 shares, representing 0.65% for KRW 2,859.89 million.
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.
Ilyang Pharmaceutical Co.,Ltd(KOSE:A007570) dropped from KOSPI 200 Index
Boryung Pharmaceutical : S.Korea sticks to flu vaccine plan despite safety fears after 25 die
Boryung Pharmaceutical : Number of South Koreans dying after flu shot rises, prompts vaccine worries
Il-Yang Pharmaceutical Signs Licence with Laboratorios Biopas to Export Leukemia Drug Supect to Colombia
Ilyang Pharmaceutical Co., Ltd announced that it has received KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Investment & Securities Co.,Ltd., and SBI Savings Bank Inc., Investment Arm.
Ilyang Pharmaceutical Co., Ltd announced that it expects to receive KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Private Equity, and SBI Savings Bank Inc., Investment Arm.
Ilyang Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till September 25, 2022.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A007570
  4. Actualités Ilyang Pharmaceutical Co.,Ltd
  5. Autres langues